Ticker	Volume	Price	Price Delta
DJIA	15,387.60	+52.30	0.34%
S&P 500	1,669.16	+2.87	0.17%
Nasdaq	3,502.12	+5.69	0.16%

Ticker

Volume

Price

Price Delta

DJIA

15,387.60

+52.30

0.34%

S&P 500

1,669.16

+2.87

0.17%

Nasdaq

3,502.12

+5.69

0.16%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,545.40	+164.35	1.07%
Hang Seng	23,366.40	-126.66	-0.54%
S&P/ASX 200	5,167.90	-12.16	-0.23%

Ticker

Volume

Price

Price Delta

Nikkei

15,545.40

+164.35

1.07%

Hang Seng

23,366.40

-126.66

-0.54%

S&P/ASX 200

5,167.90

-12.16

-0.23%

Exchange: ASE
Sector: Consumer, Non-cyclical
Industry: Healthcare-Products
Sub-Industry: Patient Monitoring Equip

Compumedics Ltd

+ Add to Watchlist

CMP:AU

0.0500 AUD 0.00000.00%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 21:41:53 ET on 05/12/2013.

Snapshot for Compumedics Ltd (CMP)

Open:	-	Day's Range:	-	Volume:	5,000
Previous Close:	0.0500	52wk Range:	0.0400 - 0.1100	1-Yr Rtn:	-

Stock Chart for CMP

No chart data available.

CMP:AU 0.0500

0.0500

Interactive CMP Chart

…

Previous Close

Key Statistics for CMP

Current P/E Ratio (ttm)	-
Estimated P/E(-)	-
Relative P/E vs. AS51	-
Earnings Per Share (ttm)	-0.0240
Est. EPS	-
Est. PEG Ratio	-
Market Cap (M AUD)	8.10
Shares Outstanding (M)	161.98
30 Day Average Volume	2,622
Price/Book (mrq)	0.8789
Price/Sale (ttm)	0.2949
Dividend Indicated Gross Yield	-%
Cash Dividend (AUD)	0.0050
Last Dividend	11/23/2004
5 Year Dividend Growth	-
Next Earnings Announcement	09/02/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMP

Revenue
Net Income (M/AUD)

Profit Margin (%)

Company Profile & Key Executives for CMP

Compumedics Limited develops computer-based medical monitoring and diagnostic equipment, which are supplied to hospitals, clinics, universities and research organizations throughout the world. The Group's systems are used in the examination and analysis of issues relating to cardiology, neurology, electromyography and sleeping disorders.